Sucampo Provides Upd
Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition
January 07, 2016 07:00 ET | Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...
Sucampo Reports Firs
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
May 06, 2015 06:30 ET | Sucampo Pharmaceuticals Inc
Strong Financial Performance Driven by Continued Revenue and Sales Growth of AMITIZA Strong Growth in Net Income and EPS Company Confirms 2015 Earnings Guidance Company to Host Conference Call...
Sucampo Announces Se
Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA
October 09, 2014 16:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd. (RTU), Takeda...
Sucampo Announces De
Sucampo Announces Departure of Chief Financial Officer
October 06, 2014 16:02 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Cary J. Claiborne, Chief Financial...
Sucampo Announces Ne
Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone
August 21, 2014 16:30 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that its subsidiary, Sucampo AG, has signed...
Sucampo Reports Seco
Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update
August 05, 2014 06:15 ET | Sucampo Pharmaceuticals Inc
Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review Company Raises Full Year 2014...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5
July 22, 2014 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2014...
Sucampo Issues State
Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote
June 12, 2014 14:41 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today issued the following statement regarding the...
Sucampo Announces Po
Sucampo Announces Positive Top-Line Results in Phase 1a Trials of Cobiprostone and SPI-3608
August 07, 2013 20:02 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) (Sucampo) today announced the positive top-line results of two recently completed clinical trials, a Phase...